zepbound tirzepatide patent expiration Looming GLP-1 drug expirations draw generics firms FDA Approves Zepbound for Sleep

Since training and competition create more oxidative stress and damage, athletes have a higher need for antioxidants

- ,

After insulin binds to the insulin receptor, IRS1 is one of the molecules activated to send the message

Dihexa Laboratory Research Dihexa is a synthetic peptide that has been investigated in laboratory settings involving peptide-receptor interactions, molecular signaling, protein expression, peptide chemistry, cellular biology, and experimental pharmacology

By increasing GLP-1 production or stimulating its release, this approach can complement existing therapies, such as GLP-1RAs and DPP-4 inhibitors, offering additional benefits while potentially reducing side effects

They also lost weight, however, the observed reductions in routine clinical practice were smaller than those reported in clinical trials